These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 1353767)

  • 1. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.
    Roths JB; Sidman CL
    J Clin Invest; 1992 Aug; 90(2):673-8. PubMed ID: 1353767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytes in host defense against Pneumocystis carinii.
    Beck JM; Harmsen AG
    Semin Respir Infect; 1998 Dec; 13(4):330-8. PubMed ID: 9872630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice.
    Roths JB; Sidman CL
    Infect Immun; 1993 May; 61(5):1641-9. PubMed ID: 8478052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat.
    Theus SA; Andrews RP; Steele P; Walzer PD
    J Clin Invest; 1995 Jun; 95(6):2587-93. PubMed ID: 7769101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes.
    Beck JM; Warnock ML; Curtis JL; Sniezek MJ; Arraj-Peffer SM; Kaltreider HB; Shellito JE
    Am J Respir Cell Mol Biol; 1991 Aug; 5(2):186-97. PubMed ID: 1679991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice.
    Opata MM; Hollifield ML; Lund FE; Randall TD; Dunn R; Garvy BA; Feola DJ
    J Immunol; 2015 Jul; 195(2):611-20. PubMed ID: 26041535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice.
    Hori S; Carvalho TL; Demengeot J
    Eur J Immunol; 2002 May; 32(5):1282-91. PubMed ID: 11981815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.
    Zheng M; Shellito JE; Marrero L; Zhong Q; Julian S; Ye P; Wallace V; Schwarzenberger P; Kolls JK
    J Clin Invest; 2001 Nov; 108(10):1469-74. PubMed ID: 11714738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice.
    Wiley JA; Harmsen AG
    J Immunol; 1995 Oct; 155(7):3525-9. PubMed ID: 7561048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis carinii and the immune response in disease.
    Hanano R; Kaufmann SH
    Trends Microbiol; 1998 Feb; 6(2):71-5. PubMed ID: 9507642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells.
    Kolls JK; Habetz S; Shean MK; Vazquez C; Brown JA; Lei D; Schwarzenberger P; Ye P; Nelson S; Summer WR; Shellito JE
    J Immunol; 1999 Mar; 162(5):2890-4. PubMed ID: 10072538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and host response in Pneumocystis carinii pneumonia.
    Su TH; Martin WJ
    Annu Rev Med; 1994; 45():261-72. PubMed ID: 8198382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody.
    Lund FE; Schuer K; Hollifield M; Randall TD; Garvy BA
    J Immunol; 2003 Aug; 171(3):1423-30. PubMed ID: 12874234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice.
    McAllister F; Steele C; Zheng M; Young E; Shellito JE; Marrero L; Kolls JK
    J Immunol; 2004 Jan; 172(2):1132-8. PubMed ID: 14707088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice.
    Harmsen AG; Stankiewicz M
    J Exp Med; 1990 Sep; 172(3):937-45. PubMed ID: 2117637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of type I IFNs in pulmonary complications of Pneumocystis murina infection.
    Meissner NN; Swain S; Tighe M; Harmsen A; Harmsen A
    J Immunol; 2005 May; 174(9):5462-71. PubMed ID: 15843544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD8+ lymphocytes in host defense against Pneumocystis carinii in mice.
    Beck JM; Newbury RL; Palmer BE; Warnock ML; Byrd PK; Kaltreider HB
    J Lab Clin Med; 1996 Nov; 128(5):477-87. PubMed ID: 8900290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell costimulatory molecule function determines susceptibility to infection with Pneumocystis carinii in mice.
    Beck JM; Blackmon MB; Rose CM; Kimzey SL; Preston AM; Green JM
    J Immunol; 2003 Aug; 171(4):1969-77. PubMed ID: 12902500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice.
    Harmsen AG; Chen W; Gigliotti F
    Infect Immun; 1995 Jul; 63(7):2391-5. PubMed ID: 7790048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model.
    Shellito JE; Kolls JK; Olariu R; Beck JM
    J Infect Dis; 1996 Feb; 173(2):432-9. PubMed ID: 8568306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.